Our team is excited to be part of the third annual conference of the Australasian RNA Biology and Biotechnology (A-RNA) in Melbourne! We’re eager to share our latest work in RNA therapeutics and connect with other innovators in the field. If you’re attending, drop by to learn more about our research and explore potential collaborations.
UNSW RNA Institute
Higher Education
UNSW Sydney, New South Wales 1,175 followers
A world class science, therapeutics and translational facility for improving quality of life through innovations.
About us
The UNSW RNA Institute is Australia’s leading RNA science, therapeutics and translational facility. Established with a $25 million investment from UNSW Sydney as part of a NSW RNA Bioscience Alliance, a partnership across all universities in NSW and ACT, and the NSW Government-funded $15 million NSW RNA Production and Research Network. Together, we’re building a world-leading manufacturing capability in NSW that will yield jobs, skills, and innovation in an industry with the potential to transform lives. Recently we celebrated a milestone achievement of becoming Australia’s first ISO 9001 Certified RNA Pre-clinical scale Manufacturing Facility. To be the first in Australia to attain the internationally recognised ISO 9001 registration, proves UNSW RNA Institute’s commitment and dedication to product quality and reliability as a trusted provider of RNA-based therapeutics. The UNSW RNA Institute Accelerator, the pre-clinical scale manufacturing facility of the Institute, is pivotal in building up Australia’s own pipeline in RNA therapeutics. This facility will be able to accelerate current projects from around Australia to then utilise the $96m NSW Government funded RNA GMP Pilot facility in Sydney and other similar facilities that might be built in Australia in the near future. The ISO 9001 certified UNSW RNA Institute Accelerator is a perfect bridge between a number of developmental facilities around the country. Importantly, the emerging national network of facilities, the UNSW RNA Institute Accelerator and the Sydney-based RNA GMP facility will ensure that Australian researchers and innovators in the RNA therapeutics space are able to maximise the value of their own intellectual property onshore from discovery to the approved clinical product.
- Website
-
https://www.unswrna.institute
External link for UNSW RNA Institute
- Industry
- Higher Education
- Company size
- 11-50 employees
- Headquarters
- UNSW Sydney, New South Wales
- Founded
- 2022
Updates
-
The UNSW RNA Institute is thrilled to be participating in BioJapan 2024, Asia's largest partnering event for the biotechnology and pharmaceutical industries. As a hub for cutting-edge research in RNA-based technologies, we look forward to connecting with global experts and innovators in drug development, diagnostics, and beyond. Join us as we shape the future of biotechnology. BioJapan 2024, 9-11 Oct, Yokohama – https://lnkd.in/ggQNjtWd Joshua Peterson (Chief Operating Officer) Andre Serobian (Chief Innovation & Commercialisation Officer) Hiroki Suyama (Scientist - RNA Analytics)
-
-
Reminder: Applications Now Open for 2024-25 Pipeline Accelerator & TFA Vouchers!
APPLICATIONS FOR PIPELINE ACCELERATOR AND TECHNICAL FEASIBILITY ASSESSMENTS (TFA) 2024-25 ROUND 1 VOUCHERS ARE NOW OPEN In this Pipeline Accelerator round, we continue to partner with two National Collaborative Research Infrastructure Strategy (NCRIS) organisations - Phenomics Australia and National Deuteration Facility (NDF) ANSTO, to expand the portfolio of services and expertise enabling medical research discovery and translation. This scheme aims to support therapeutic development projects by providing up to $50,000 with at least 50% matching funding (co-investment) by the applicant. We are pleased to announce the expansion of this scheme to include subsidised access to several new facilities, including GLP toxicology and preclinical research-grade viral vector production. 👉 Learn more here: https://lnkd.in/grjx9VWK We also provide support for TFAs for Cell & Gene Therapy (CGT) research projects. The TFAs will provide researchers with much needed direction for initiating translational research, building knowledge of the process and requirements and improving early-stage decisions. 👉 Learn more here: https://lnkd.in/g-47w5NC ⚠ Applications close 31st October, 5PM AEST ⚠ Info Session Join us on Tuesday the 10th of September at 1pm (AEST) for an info session. This webinar will outline how researchers from the public and private sectors can apply for vouchers to gain additional subsidised access to a range of services and expertise from several NCRIS facilities. These facilities offer expert advice, services and support for development of therapeutic products. 👉 REGISTER HERE: https://lnkd.in/gt4znhRd
-
-
RNA meets supramolecular peptide chemistry! And yes, it is not just about charge interactions!
Latest Preprint from our research: Arginine-rich peptides discriminate between purine- and pyrimidine-only RNA! Our latest preprint is out @ChemRxiv We also demonstrate how macromolecular crowding modulates RNA-peptide condensates. Congrats to Anika Moller, Isis Middleton, Grace Maynard & Hsiu Lin Li from Thordarson group & to Anna Wang on this achievement - it has been a fantastic collaboraiton. Do let us know if you have any comments on this work. UNSW RNA Institute School of Chemistry, UNSW Sydney #RNA #mRNA #ozchem #supramolecular https://lnkd.in/gHaCJpSF
-
-
🌟 Congratulations to Dr Selene Fernandez-Valverde from UNSW RNA Institute for being awarded an Australian Research Council (ARC) Future Fellowship! 🌟 This prestigious fellowship recognises Dr Fernandez-Valverde’s outstanding work in plant genetics and epigenetics, securing $983,000 in funding. Her research aims to study plant RNA binding proteins and RNA structures, contributing to the development of synthetic regulatory RNAs. This groundbreaking work has the potential to create market-friendly plants resistant to pests and extreme climates. https://lnkd.in/gUmeY-Pv
-
-
Congratulations to University of Technology Sydney + Iain Duggin and Garry Myers on leading this exciting project with CSIRO Professor Branwen Morgan and her team, Garvan Institute of Medical Research and Deborah Burnett ! We at the UNSW RNA Institute are very proud to be part of this important collaboration on mRNA vaccines against UTI. A true Team Australia approach - #mRNA Ed Husic MP Cathy Foley Office of the NSW Chief Scientist & Engineer RNA Australia NSW Health NSW Medical Research Myeloid Therapeutics
📢 Exciting News from the UNSW RNA Institute! We are thrilled to announce our collaboration on a groundbreaking research project led by the University of Technology Sydney (UTS). This project, which also includes the CSIRO, Garvan Institute of Medical Research, Biointelect Pty Ltd, NSW Health, and Starpharma, has secured a $1.8 million grant from the Australian Government Medical Research Future Fund (MRFF) to develop an mRNA vaccine for urinary tract infections (UTIs). UTIs represent a significant health challenge globally, affecting millions of people annually. The rise of antibiotic-resistant strains of bacteria like Escherichia coli has made it imperative to find new solutions. This innovative project aims to address this issue with cutting-edge mRNA technology, potentially transforming the prevention and treatment of recurrent UTIs. We look forward to advancing this critical research and contributing to the development of effective UTI interventions. Stay tuned for more updates on this important project! Read more: https://lnkd.in/gJ-hrKR2
-
-
📢 Exciting News from the UNSW RNA Institute! We are thrilled to announce our collaboration on a groundbreaking research project led by the University of Technology Sydney (UTS). This project, which also includes the CSIRO, Garvan Institute of Medical Research, Biointelect Pty Ltd, NSW Health, and Starpharma, has secured a $1.8 million grant from the Australian Government Medical Research Future Fund (MRFF) to develop an mRNA vaccine for urinary tract infections (UTIs). UTIs represent a significant health challenge globally, affecting millions of people annually. The rise of antibiotic-resistant strains of bacteria like Escherichia coli has made it imperative to find new solutions. This innovative project aims to address this issue with cutting-edge mRNA technology, potentially transforming the prevention and treatment of recurrent UTIs. We look forward to advancing this critical research and contributing to the development of effective UTI interventions. Stay tuned for more updates on this important project! Read more: https://lnkd.in/gJ-hrKR2
-
-
📣 Join Us: Scientist Position at the UNSW RNA Institute 📣 The UNSW RNA Institute is Australia’s leading RNA research institute, bringing together researchers from UNSW Science, Engineering and Medicine, under the leadership of Professor Pall Thordarson. We’re seeking a Scientist to carry out research, development and production of RNA and related products within the UNSW RNA Institute. Apply now: https://lnkd.in/ghmkj7xs
-
-
Very proud of Amir Akbari and the rest of my research group that presented at the 14th International Nanomedicine Conference #Oznanomed in Sydney!
Had a great experience presenting my research poster at the 14th International Nano-Medicine Conference in Sydney. It was a valuable experience to share ideas and engage with other researchers, alongside some of our team members. . #NanoMedicine #Research #Conference #PosterPresentation #Sydney
-
-
The UNSW RNA Institute is proud to sponsor the 14th International Nanomedicine here in Sydney. #Oznanomed #mRNA #nanomed #ozchem
Jean-Frederic Levesque Chief Executive NSW Agency for Clinical Innovation NSW Health kicks off the 14th International Nanomedicine Conference here in Sydney. Held here in Sydney annually since 2010 this conference has been the cornerstone of Nanomedicine research in Sydney and a key reason why we are in such a strong position in Nanomedicine, which in turns underpins our strengths in delivery science, advanced sensor technology and RNA therapeutics - all critical areas in advanced manufacturing. Office of the NSW Chief Scientist & Engineer Chris Minns ANSTO CSIRO UNSW UNSW RNA Institute #ozchem #mRNA Ed Husic MP Cathy Foley
-